Business
Vor Bio to Participate in the Goldman Sachs Healthcare Conference
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will present and host
About this update from Vor Biopharma Inc.
[{"type":"text","content":"CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will present and host in-person 1x1 investor meetings at the Goldman Sachs 44th Annual Global Healthcare Conference. Goldman Sachs 44th Annual Global Healthcare ConferenceFireside Chat: Monday, June 12, 2023 at 8:00am PTLocation: Waldorf Astoria Monarch Beach Resort & Club, Dana Point, CA A live webcast and archived replay of the fireside chat will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/ About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 [email protected] \nSource: Vor Biopharma","length":2710,"tagName":"div"}]